3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy

Journal of Medicinal Chemistry
Lorna PiazziMaurizio Recanatini

Abstract

In recent years, the investigation of acetylcholinesterase (AChE) inhibitors has gained further interest, because the involvement of the peripheral site of the enzyme in the beta-amyloid (Abeta) aggregation process has been disclosed. We present here, for the first time, a direct evidence of the Abeta antiaggregating action of an AChE inhibitor (AP2238) purposely designed to bind at both the catalytic and the peripheral sites of the human enzyme.

References

Oct 25, 1982·Journal of Molecular Biology·I D KuntzT E Ferrin
Jan 19, 2000·Current Medicinal Chemistry·H SugimotoY Kawakami
Apr 3, 2001·Nature Reviews. Neuroscience·H Soreq, S Seidman
Sep 7, 2001·Journal of Medicinal Chemistry·C BrühlmannA Carotti
Jul 18, 2002·Trends in Pharmacological Sciences·Diana Ines Dominguez, Bart De Strooper
Jan 16, 2003·Biochemical Pharmacology·Manuela BartoliniVincenza Andrisano
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Sep 1, 2001·Expert Review of Neurotherapeutics·S Moghul, D Wilkinson

❮ Previous
Next ❯

Citations

Jun 2, 2007·Analytical and Bioanalytical Chemistry·Francesca ManciniVincenza Andrisano
Feb 26, 2013·Archives of Pharmacal Research·Preet Anand, Baldev Singh
Apr 10, 2013·Analytica Chimica Acta·Anthony J VelosoKagan Kerman
Jun 24, 2008·Chemico-biological Interactions·S AkasofuH Ogura
Feb 22, 2014·European Journal of Medicinal Chemistry·Nilima A VyasBimba Joshi
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Maria Laura BolognesiCarlo Melchiorre
Dec 5, 2006·Molecular Pharmaceutics·Lisa M EubanksKim D Janda
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Levi L Blazer, Richard R Neubig
May 25, 2011·Chemical Communications : Chem Comm·Hiroto YoshidaJoji Ohshita
Jun 11, 2004·Clinical Neuropharmacology·Roger M LaneNigel H Greig
Jul 16, 2014·BioMed Research International·Manisha GoyalAbhinav Grover
Apr 28, 2005·Expert Review of Neurotherapeutics·Andrea TaskerClive G Ballard
Dec 24, 2005·Expert Opinion on Investigational Drugs·Ana Martinez, Ana Castro
Nov 29, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Kadir Ozden YerdelenBaris Anil
Sep 3, 2010·Journal of Enzyme Inhibition and Medicinal Chemistry·C M González Tanarro, M Gütschow
Apr 6, 2012·Expert Opinion on Therapeutic Patents·Christos KontogiorgisDimitra Hadjipavlou-Litina
May 13, 2017·Future Medicinal Chemistry·Eva RamosAlejandro Romero
Jun 24, 2004·Journal of Neuroscience Research·Thole ZüchnerReinhard Schliebs
Feb 28, 2006·Journal of the American Medical Directors Association·John B Standridge
Jan 15, 2005·Progress in Neurobiology·Carlos MorganNibaldo C Inestrosa
Jul 1, 2008·Bioorganic & Medicinal Chemistry·Francesco LeonettiAngelo Carotti
Jul 13, 2017·Archiv der Pharmazie·Suchita PrasadSunil K Sharma
Jan 18, 2017·Journal of Enzyme Inhibition and Medicinal Chemistry·Fatih SonmezSalvatore Guccione
Jul 28, 2017·Journal of Medicinal Chemistry·Federica PratiAndrea Cavalli
Feb 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Angela StefanachiAngelo Carotti
Dec 17, 2014·Pharmacology Research & Perspectives·Andrea TarozziAngela Rampa
Apr 14, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Irini DoytchinovaIvan Dimitrov
Apr 14, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Rosanna CaliandroDoriano Lamba
Mar 2, 2005·Journal of Computational Chemistry·T K ManojkumarKwang S Kim
Mar 19, 2009·The FEBS Journal·Markus PietschMichael Gütschow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.